Merck’s COVID-19 pill active against Omicron in lab studies
Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
Synopsis: The Therapeutic Goods Administration has provisionally approved the Comirnaty (Pfizer) vaccine as safe and effective for use among 5 to 11-year-old…
KEYPOINTS: The UK became the first country to approve Covid-19 antiviral pill, jointly developed by US-based Merck & Co Inc and Ridgeback…